Agilent Apoptosis detection by annexin V active caspase-3 with the Agilent 2100 bioanalyzer Manual

Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer


Agilent Apoptosis detection by annexin V active caspase-3 with the Agilent 2100 bioanalyzer Manual - cover page
Brand
Agilent
Document type
Application Note
Language
English
Pages
8
File format
PDF
File size
106 KB
Published
11 June, 2012
Updated
30 September, 2023
MD5 checksum
D19522FEA001078D5EEEABE62A7785B5

About this manual

This document details how the Agilent 2100 bioanalyzer can be used to analyze apoptotic cell samples, comparing its performance with conventional flow cytometry. It demonstrates that the microfluidic system provides data quality in good agreement with traditional methods while requiring fewer cells.

The note provides detailed protocols and reagent recommendations for two specific assays: an annexin V assay to detect phosphatidyl serine exposure and a caspase-3 assay to measure active proteases. It highlights the system's advantages, including high reproducibility, low cell consumption, and ease of use.

What's inside

  • Introduction
  • Apoptosis Mechanisms
  • Experimental Setup
  • Annexin V Staining Results
  • Caspase-3 Assay
  • Data Comparison with Flow Cytometry

Frequently asked questions

What are the advantages of using the Agilent 2100 bioanalyzer for apoptosis assays?

The system offers high reproducibility, low cell consumption, and ease-of-use.

How does the Agilent 2100 bioanalyzer compare to a conventional flow cytometer?

The histogram quality of fluorescent cells counted with the microfluidic system is in good agreement with data obtained with a flow cytometer.

Download PDF (106 KB)

More Agilent Manuals


View all Agilent manuals →